Advancing excellence in laboratory medicine for better healthcare worldwide

Molecular Diagnostic Centres Expert Laboratory

 

Click here to download the MDC Document: Process for review of applications and selection of Molecular Diagnostic Centers  

Click here to download the " Molecular Diagnostics Centers Network APPLICATION FORM" and the " Molecular Diagnostics Expert APPLICATION FORM"

 

About the Molecular Diagnostic Centres (MDC) Project of IFCC C-MD

Each MDC which is formed will represent an interface between the IFCC C-MD and clinical laboratories performing molecular diagnostic tests. The MDC concept was formulated to promote formation of an international network of molecular diagnostic laboratories and to encourage close collaboration within this network. This approach supports the IFCC-CMD's broader initiatives for excellence and international collaborations in molecular diagnostics.

 

Terms of reference of the MDCs

  • To provide a point of contact to Molecular Diagnostic Laboratories in the analysis and/or interpretation of complex analytical/clinical scenarios.
  • To participate in international studies involving the evaluation of new methodological approaches. 


MDC fields of application and joining a MDC Expert Laboratory

Individuals and organizations can apply to join an MDC network by completion of an application form. There are two levels of participation, including participation as an IFCC MDC Network Member or as an IFCC MDC Expert Laboratory.

IFCC MDC Expert Laboratories will be engaged at a higher level and act as a point of reference within a special area of interest within the IFCC MDC Network. Progress reports on the activities of Expert Laboratories are submitted to the C-MD for review. Further details are available on the application form.

Examples of fields of application

  • cystic fibrosis,
  • haemochromatosis
  • dyslipidaemias Fragile X
  • pharmacogenetics

Examples of molecular oncology fields of application

  • breast cancer
  • melanoma
  • gene amplification circulating tumour cells
  • laser microdissection
  • acquired rearrangements 

 

GERMANY

Prof. Dr. med. Michael Neumaier

Institute for Clinical Chemistry
Medical Faculty Mannheim of the University of Heidelberg
University Hospital Mannheim
Theodor-Kutzer-Ufer 1-3
68167 Mannheim
Germany
Email: michael.neumaier@medma.uni-heidelberg.de

 

MDC Network Area of Interest

 

Examples

Specific Area

Single-Gene Disorders

Hemochromatosis, Fragile X, Cystic Fibrosis, Factor V Leiden

Hemocromatosis, Thrombophilia

Oncology

Solid Organ: Breast, colon, lungs, therapeutic response, prognostic testing

Molecular Oncology
Pharmacogenetics

CYP2D6, TPMT

 

 

THE NETHERLANDS

Dr. Ron Van Schaik 

Dept. Clinical Chemistry
Erasmus University Medical Center
P.O. Box 2040
3000 CA Rotterdam
The Netherlands
email r.vanschaik@erasmusmc.nl

 

MDC Network Area of Interest

 

Examples

Specific Area

 Pharmacogenetics

CYP2D6, TPMT

 

 

SPAIN

Dr. Maria Isabel Tejada

 

Laboratorio de Genética Molecular
Servicio de Genética
Hospital Universitario Cruces
Pza. de Cruces s/n
48903-Barakaldo (Bizkaia)
Spain
Email: MARIAISABEL.TEJADAMINGUEZ@osakidetza.net

  

MDC Network Area of Interest

 

Examples

Specific Area

Single-Gene Disorders

Hemochromatosis, Fragile X, Cystic Fibrosis, Factor V Leide

XLID (Fragile-X included)

Oncology

Solid Organ: Breast, colon, lungs, therapeutic response, prognostic testing

Hereditary Breast Cancer

 

 

UK

Dr. Colin Graham

Regional Genetics Laboratories
(co-applicant: Regional Lipid Clinic)
Belfast Health and Social Care Trust
Belfast City Hospital
Lisburn Rd.
Belfast  BT97AB - UK
Email:  colin.graham@belfasttrust.hscni.net

 

MDC Network Area of Interest

 

Examples

Specific Area

Multi-Gene Disorders

Dyslipidaemias

 

 
Website developed by Insoft Digital